Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium falciparum | plasmepsin VI | 0.0196 | 0.048 | 0.0999 |
Loa Loa (eye worm) | hypothetical protein | 0.0116 | 0.0024 | 0.0024 |
Brugia malayi | hypothetical protein | 0.0115 | 0.0018 | 0.0018 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0046 | 0.0046 |
Echinococcus multilocularis | Mastin | 0.0115 | 0.0018 | 0.0064 |
Loa Loa (eye worm) | hypothetical protein | 0.0205 | 0.0536 | 0.0536 |
Brugia malayi | Chymotrypsin-like protease CTRL-1 precursor | 0.0115 | 0.0018 | 0.0018 |
Echinococcus multilocularis | subfamily S1A unassigned peptidase (S01 family) | 0.0115 | 0.0018 | 0.0064 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.0018 | 0.0018 |
Onchocerca volvulus | 0.0372 | 0.1493 | 1 | |
Echinococcus granulosus | Mastin | 0.0115 | 0.0018 | 0.0064 |
Loa Loa (eye worm) | hypothetical protein | 0.0205 | 0.0536 | 0.0536 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.012 | 0.0046 | 0.0104 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0205 | 0.0536 | 0.1962 |
Brugia malayi | Trypsin-like protease protein 5 | 0.0115 | 0.0018 | 0.0018 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.012 | 0.0046 | 0.0104 |
Plasmodium falciparum | plasmepsin IX | 0.028 | 0.0963 | 0.2112 |
Echinococcus granulosus | transmembrane protease serine 3 | 0.0115 | 0.0018 | 0.0064 |
Brugia malayi | Protein kinase domain containing protein | 0.0372 | 0.1493 | 0.1493 |
Loa Loa (eye worm) | trypsin family protein | 0.0115 | 0.0018 | 0.0018 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.012 | 0.0046 | 0.0104 |
Plasmodium vivax | cysteine repeat modular protein 1, putative | 0.0372 | 0.1493 | 0.3331 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.012 | 0.0046 | 0.0104 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.012 | 0.0046 | 0.0104 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.0018 | 0.0018 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.0196 | 0.048 | 0.3172 |
Loa Loa (eye worm) | aspartic protease BmAsp-1 | 0.012 | 0.0046 | 0.0046 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0575 | 0.2657 | 1 |
Brugia malayi | Trypsin family protein | 0.0115 | 0.0018 | 0.0018 |
Loa Loa (eye worm) | hypothetical protein | 0.012 | 0.0046 | 0.0046 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.0196 | 0.048 | 0.048 |
Loa Loa (eye worm) | angiotensin-converting enzyme family protein | 0.1854 | 1 | 1 |
Echinococcus multilocularis | transmembrane protease serine 3 | 0.0115 | 0.0018 | 0.0064 |
Loa Loa (eye worm) | aspartyl protease 6 | 0.012 | 0.0046 | 0.0046 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.012 | 0.0046 | 0.0104 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.0196 | 0.048 | 0.1186 |
Brugia malayi | Integrin beta pat-3 precursor | 0.0303 | 0.1097 | 0.1097 |
Plasmodium falciparum | plasmepsin I | 0.0196 | 0.048 | 0.0999 |
Plasmodium falciparum | plasmepsin X | 0.028 | 0.0963 | 0.2112 |
Loa Loa (eye worm) | integrin alpha pat-2 | 0.0228 | 0.0667 | 0.0667 |
Echinococcus multilocularis | Peptidase S1 S6, chymotrypsin Hap | 0.0115 | 0.0018 | 0.0064 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.012 | 0.0046 | 0.0104 |
Loa Loa (eye worm) | TK/ROR protein kinase | 0.0372 | 0.1493 | 0.1493 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0196 | 0.048 | 0.0999 |
Brugia malayi | Pepsin A precursor | 0.012 | 0.0046 | 0.0046 |
Plasmodium vivax | aspartyl protease, putative | 0.028 | 0.0963 | 0.2112 |
Echinococcus granulosus | tissue type plasminogen activator | 0.0372 | 0.1493 | 1 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.0196 | 0.048 | 0.1186 |
Echinococcus multilocularis | integrin beta 2 | 0.0225 | 0.0646 | 0.4297 |
Toxoplasma gondii | kringle domain-containing protein | 0.0372 | 0.1493 | 0.3958 |
Schistosoma mansoni | hypothetical protein | 0.0372 | 0.1493 | 0.5588 |
Brugia malayi | Trypsin family protein | 0.0115 | 0.0018 | 0.0018 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.0018 | 0.0018 |
Loa Loa (eye worm) | integrin beta-2 | 0.0303 | 0.1097 | 0.1097 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.012 | 0.0046 | 0.0104 |
Echinococcus granulosus | enteropeptidase | 0.0115 | 0.0018 | 0.0064 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.0196 | 0.048 | 0.5 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0196 | 0.048 | 0.1748 |
Echinococcus multilocularis | enteropeptidase | 0.0115 | 0.0018 | 0.0064 |
Echinococcus multilocularis | glycoprotein Antigen 5 | 0.0115 | 0.0018 | 0.0064 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0205 | 0.0536 | 0.1962 |
Plasmodium vivax | plasmepsin IV, putative | 0.0196 | 0.048 | 0.0999 |
Onchocerca volvulus | 0.012 | 0.0046 | 0.0187 | |
Brugia malayi | aspartic protease BmAsp-2, identical | 0.012 | 0.0046 | 0.0046 |
Echinococcus granulosus | Peptidase S1 S6 chymotrypsin Hap | 0.0115 | 0.0018 | 0.0064 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0372 | 0.1493 | 0.5 |
Schistosoma mansoni | integrin alpha | 0.0148 | 0.0207 | 0.0715 |
Echinococcus multilocularis | tissue type plasminogen activator | 0.0372 | 0.1493 | 1 |
Plasmodium vivax | aspartyl protease, putative | 0.028 | 0.0963 | 0.2112 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.0018 | 0.0018 |
Brugia malayi | Integrin alpha pat-2 precursor | 0.0148 | 0.0207 | 0.0207 |
Leishmania major | hypothetical protein, conserved | 0.0372 | 0.1493 | 0.5 |
Plasmodium falciparum | cysteine repeat modular protein 1 | 0.0372 | 0.1493 | 0.3331 |
Schistosoma mansoni | integrin beta subunit | 0.0179 | 0.0382 | 0.1379 |
Loa Loa (eye worm) | hypothetical protein | 0.0372 | 0.1493 | 0.1493 |
Echinococcus granulosus | integrin beta 2 | 0.0225 | 0.0646 | 0.4297 |
Plasmodium falciparum | plasmepsin V | 0.0877 | 0.4391 | 1 |
Onchocerca volvulus | 0.012 | 0.0046 | 0.0187 | |
Brugia malayi | Kringle domain containing protein | 0.0372 | 0.1493 | 0.1493 |
Toxoplasma gondii | aspartyl protease ASP5 | 0.0757 | 0.3703 | 1 |
Brugia malayi | hypothetical protein | 0.012 | 0.0046 | 0.0046 |
Brugia malayi | hypothetical protein | 0.012 | 0.0046 | 0.0046 |
Brugia malayi | aspartic protease BmAsp-1, identical | 0.012 | 0.0046 | 0.0046 |
Brugia malayi | Eukaryotic aspartyl protease family protein | 0.012 | 0.0046 | 0.0046 |
Mycobacterium ulcerans | hypothetical protein | 0.0115 | 0.0018 | 0.5 |
Brugia malayi | Trypsin family protein | 0.0205 | 0.0536 | 0.0536 |
Onchocerca volvulus | 0.0205 | 0.0536 | 0.3511 | |
Echinococcus granulosus | glycoprotein Antigen 5 | 0.0115 | 0.0018 | 0.0064 |
Toxoplasma gondii | aspartyl protease ASP3 | 0.028 | 0.0963 | 0.2509 |
Plasmodium vivax | plasmepsin V, putative | 0.0877 | 0.4391 | 1 |
Brugia malayi | Trypsin family protein | 0.0115 | 0.0018 | 0.0018 |
Loa Loa (eye worm) | hypothetical protein | 0.0196 | 0.048 | 0.048 |
Echinococcus granulosus | subfamily S1A unassigned peptidase S01 family | 0.0115 | 0.0018 | 0.0064 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.0575 | 0.2657 | 1 |
Plasmodium falciparum | plasmepsin IV | 0.0196 | 0.048 | 0.0999 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.0196 | 0.048 | 0.3172 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.0018 | 0.0018 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.012 | 0.0046 | 0.0104 |
Plasmodium falciparum | plasmepsin II | 0.0196 | 0.048 | 0.0999 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.098 ug ml-1 | Cytotoxic activity against murine P388 leukemia cells | ChEMBL. | 15056007 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.